MLi-2 is a structurally novel, highly potent, and selective LRRK2 kinase inhibitor with central nervous system activity. MLi-2 exhibits exceptional potency in a purified LRRK2 kinase assay in vitro (IC50 = 0.76 nM), a cellular assay monitoring dephosphorylation of LRRK2 pSer935 LRRK2 (IC50 = 1.4 nM), and a radioligand competition binding assay (IC50 = 3.4 nM).
Molecular Weight:
379.46
Purity:
98.96%
CAS Number:
[1627091-47-7]
Formula:
C21H25N5O2
Target:
LRRK2
T16115
* VAT and and shipping costs not included. Errors and price changes excepted
